SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
COVIDSurg Collaborative; GlobalSurg Collaborative
Anaesthesia 2022;77:28-39.
Review by C. M. Samama
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.
Baksaas-Aasen K, Gall LS, Stensballe J, et al.
Intensive Care Med 2021;47:49-59.
Review by D. Faraoni
Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019.
Maatman TK, Jalali F, Feizpour C, et al.
Crit Care Med 2020;48:e783-e790.
Review by C. M. Samama
Fibrinogen concentrate to cardiac surgery patients with ongoing bleeding does not increase the risk of thromboembolic complications or death.
Waldén K, Jeppsson A, Nasic S, Karlsson M
Thromb Haemost 2020;120:384-391.
Review by H. B. Ravn
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Male C, Lensing AWA, Palumbo JS, et al.
Lancet Haematol 2020;7:e18-e27.
Review by J. M. Cholette
Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death.
Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al.
Blood 2019;134:2354-2360.
Review by J. M. Cholette
Association of timing of plasma transfusion with adverse maternal outcomes in women with persistent postpartum hemorrhage.
Henriquez D, Caram-Deelder C, le Cessie S, et al.
JAMA Netw Open 2019;2:e1915628.
Review by B. J. Hunt
Four years’ experience of a ROTEM((R))-guided algorithm for treatment of coagulopathy in obstetric haemorrhage.
McNamara H, Kenyon C, Smith R, Mallaiah S, Barclay P
Anaesthesia 2019;74:984-991.
Review by B. Froessler
Tranexamic acid administration is not associated with an increase in complications in high-risk patients undergoing primary total knee or total hip arthroplasty: a retrospective case-control study of 38,220 patients.
Porter SB, White LJ, Osagiede O, Robards CB, Spaulding AC
J Arthroplasty 2020;35:45-51.
Review by M. T. Prochaska
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
Habbab LM, Hussain S, Power P, et al.
J Card Surg 2019;34:305-311.
Review by H. B. Ravn
Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes.
Chaudhury P, Gadre S, Schneider E, et al.
Am J Cardiol 2019;124:1465-1469.
Review by J. M. Cholette
Association of blood component ratios with 24-hour mortality in injured children receiving massive transfusion.
Butler EK, Mills BM, Arbabi S, et al.
Crit Care Med 2019;47:975-983.
Review by D. Faraoni
4-factor prothrombin complex concentrate is associated with improved survival in trauma related hemorrhage: a nationwide propensity matched analysis.
Zeeshan M, Hamidi M, Feinstein AJ, et al.
J Trauma Acute Care Surg 2019;87:274-281.
Review by J.-F. Hardy
Fibrinogen concentrate as an alternative to cryoprecipitate in a postcardiopulmonary transfusion algorithm in infants undergoing cardiac surgery: a prospective randomized controlled trial.
Downey LA, Andrews J, Hedlin H, et al.
Anesth Analg 2020;130:740-751.
Review by E. Adams
A regional massive hemorrhage protocol developed through a modified Delphi technique.
Callum JL, Yeh CH, Petrosoniak A, et al.
CMAJ Open 2019;7:E546-E561.
Review by E. Adams
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659